© The Rockefeller University Press, 0022-1007/1997/4/1203/ $5.00
The Journal of Experimental Medicine, Volume 185, Number 7, April 7, 1997 1203-1210
Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity
Shingo Yamamoto*,
,
Yoshifumi Takeda
,
,
Masafumi Yamamoto*,
Hisao Kurazono*,
Koichi Imaoka*,
Miho Yamamoto*,
Kohtaro Fujihashi*,
Masatoshi Noda||,
Hiroshi Kiyono*,¶, and
Jerry R. McGhee*
From the * Immunobiology Vaccine Center and Department of Microbiology and Department of Oral Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294;
Department of Microbiology, Faculty of Medicine, Kyoto University, Kyoto 606, Japan;
Research Institute, International Medical Center of Japan, Shinjuku-ku, Tokyo 162, Japan; || Second Department of Microbiology, Faculty of Medicine, Chiba University, Chuo-ku, Chiba 260, Japan; and ¶ Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Cholera toxin (CT), the most commonly used mucosal adjuvant in experimental animals, is unsuitable for humans because of potent diarrhea-inducing properties. We have constructed two CT-A subunit mutants, e.g., serine
phenylalanine at position 61 (S61F), and glutamic acid
lysine at 112 (E112K) by site-directed mutagenesis. Neither mutant CT (mCT), in contrast to native CT (nCT), induced adenosine diphosphate-ribosylation, cyclic adenosine monophosphate formation, or fluid accumulation in ligated mouse ileal loops. Both mCTs retained adjuvant properties, since mice given ovalbumin (OVA) subcutaneously with mCTs or nCT, but not OVA alone developed high-titered serum anti-OVA immunoglobulin G (IgG) antibodies (Abs) which were largely of IgG1 and IgG2b subclasses. Although nCT induced brisk IgE Ab responses, both mCTs elicited lower anti-OVA IgE Abs. OVA-specific CD4+ T cells were induced by nCT and by mCTs, and quantitative analysis of secreted cytokines and mRNA revealed a T helper cell 2 (Th2)-type response. These results now show that the toxic properties of CT can be separated from adjuvanticity, and the mCTs induce Ab responses via a Th2 cell pathway.
Address correspondence to Dr. Jerry R. McGhee, Immunobiology Vaccine Center and the Department of Microbiology, University of Alabama at Birmingham, 845 19th Street South, Birmingham, Alabama 352942170.
1Abbreviations used in this paper: AFC, antibody-forming cell; CHO, Chinese hamster ovary; CT, cholera toxin; ELISPOT, enzyme-linked immunospot; LT, heat-labile toxin; m, mutant; n, native; r, recombinant; RT, reverse transcriptase; S, secretory.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Negri, D. R. M., Pinto, D., Vendetti, S., Patrizio, M., Sanchez, M., Riccomi, A., Ruggiero, P., Del Giudice, G., De Magistris, M. T.
(2009). Cholera Toxin and Escherichia coli Heat-Labile Enterotoxin, but Not Their Nontoxic Counterparts, Improve the Antigen-Presenting Cell Function of Human B Lymphocytes. Infect. Immun.
77: 1924-1935
[Abstract]
[Full Text]
-
Momoi, F., Hashizume, T., Kurita-Ochiai, T., Yuki, Y., Kiyono, H., Yamamoto, M.
(2008). Nasal Vaccination with the 40-Kilodalton Outer Membrane Protein of Porphyromonas gingivalis and a Nontoxic Chimeric Enterotoxin Adjuvant Induces Long-Term Protective Immunity with Reduced Levels of Immunoglobulin E Antibodies. Infect. Immun.
76: 2777-2784
[Abstract]
[Full Text]
-
Wakabayashi, A., Nakagawa, Y., Shimizu, M., Moriya, K., Nishiyama, Y., Takahashi, H.
(2008). Suppression of an Already Established Tumor Growing through Activated Mucosal CTLs Induced by Oral Administration of Tumor Antigen with Cholera Toxin. J. Immunol.
180: 4000-4010
[Abstract]
[Full Text]
-
Olivier, V., Salzman, N. H., Satchell, K. J. F.
(2007). Prolonged Colonization of Mice by Vibrio cholerae El Tor O1 Depends on Accessory Toxins. Infect. Immun.
75: 5043-5051
[Abstract]
[Full Text]
-
Schnitzler, A. C., Burke, J. M., Wetzler, L. M.
(2007). Induction of Cell Signaling Events by the Cholera Toxin B Subunit in Antigen-Presenting Cells. Infect. Immun.
75: 3150-3159
[Abstract]
[Full Text]
-
Becker, P. D., Bertot, G. M., Souss, D., Ebensen, T., Guzman, C. A., Grinstein, S.
(2007). Intranasal Vaccination with Recombinant Outer Membrane Protein CD and Adamantylamide Dipeptide as the Mucosal Adjuvant Enhances Pulmonary Clearance of Moraxella catarrhalis in an Experimental Murine Model. Infect. Immun.
75: 1778-1784
[Abstract]
[Full Text]
-
Hagiwara, Y., Kawamura, Y. I., Kataoka, K., Rahima, B., Jackson, R. J., Komase, K., Dohi, T., Boyaka, P. N., Takeda, Y., Kiyono, H., McGhee, J. R., Fujihashi, K.
(2006). A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking.. J. Immunol.
177: 3045-3054
[Abstract]
[Full Text]
-
van Ginkel, F. W., Jackson, R. J., Yoshino, N., Hagiwara, Y., Metzger, D. J., Connell, T. D., Vu, H. L., Martin, M., Fujihashi, K., McGhee, J. R.
(2005). Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract. Infect. Immun.
73: 6892-6902
[Abstract]
[Full Text]
-
Ohmura, M., Yamamoto, M., Tomiyama-Miyaji, C., Yuki, Y., Takeda, Y., Kiyono, H.
(2005). Nontoxic Shiga Toxin Derivatives from Escherichia coli Possess Adjuvant Activity for the Augmentation of Antigen-Specific Immune Responses via Dendritic Cell Activation. Infect. Immun.
73: 4088-4097
[Abstract]
[Full Text]
-
Alignani, D., Maletto, B., Liscovsky, M., Ropolo, A., Moron, G., Pistoresi-Palencia, M. C.
(2005). Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J. Leukoc. Biol.
77: 898-905
[Abstract]
[Full Text]
-
Borsutzky, S., Kretschmer, K., Becker, P. D., Muhlradt, P. F., Kirschning, C. J., Weiss, S., Guzman, C. A.
(2005). The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells. J. Immunol.
174: 6308-6313
[Abstract]
[Full Text]
-
Nawar, H. F., Arce, S., Russell, M. W., Connell, T. D.
(2005). Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities. Infect. Immun.
73: 1330-1342
[Abstract]
[Full Text]
-
Li, X., Erbe, J. L., Lockatell, C. V., Johnson, D. E., Jobling, M. G., Holmes, R. K., Mobley, H. L. T.
(2004). Use of Translational Fusion of the MrpH Fimbrial Adhesin-Binding Domain with the Cholera Toxin A2 Domain, Coexpressed with the Cholera Toxin B Subunit, as an Intranasal Vaccine To Prevent Experimental Urinary Tract Infection by Proteus mirabilis. Infect. Immun.
72: 7306-7310
[Abstract]
[Full Text]
-
Yoshino, N., Lu, F. X.-S., Fujihashi, K., Hagiwara, Y., Kataoka, K., Lu, D., Hirst, L., Honda, M., van Ginkel, F. W., Takeda, Y., Miller, C. J., Kiyono, H., McGhee, J. R.
(2004). A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates. J. Immunol.
173: 6850-6857
[Abstract]
[Full Text]
-
Borsutzky, S., Cazac, B. B., Roes, J., Guzman, C. A.
(2004). TGF-{beta} Receptor Signaling Is Critical for Mucosal IgA Responses. J. Immunol.
173: 3305-3309
[Abstract]
[Full Text]
-
Eriksson, A. M., Schon, K. M., Lycke, N. Y.
(2004). The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues. J. Immunol.
173: 3310-3319
[Abstract]
[Full Text]
-
Bo Su, S., Silver, P. B., Wang, P., Chan, C.-C., Caspi, R. R.
(2004). Cholera Toxin Prevents Th1-Mediated Autoimmune Disease by Inducing Immune Deviation. J. Immunol.
173: 755-761
[Abstract]
[Full Text]
-
Lavelle, E. C., Jarnicki, A., McNeela, E., Armstrong, M. E., Higgins, S. C., Leavy, O., Mills, K. H. G.
(2004). Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol.
75: 756-763
[Abstract]
[Full Text]
-
Kataoka, K., McGhee, J. R., Kobayashi, R., Fujihashi, K., Shizukuishi, S., Fujihashi, K.
(2004). Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity. J. Immunol.
172: 3612-3619
[Abstract]
[Full Text]
-
Berry, L. J., Hickey, D. K., Skelding, K. A., Bao, S., Rendina, A. M., Hansbro, P. M., Gockel, C. M., Beagley, K. W.
(2004). Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection. Infect. Immun.
72: 1019-1028
[Abstract]
[Full Text]
-
Bagley, K. C., Abdelwahab, S. F., Tuskan, R. G., Lewis, G. K.
(2003). An Enzymatically Active A Domain Is Required for Cholera-Like Enterotoxins To Induce a Long-Lived Blockade on the Induction of Oral Tolerance: New Method for Screening Mucosal Adjuvants. Infect. Immun.
71: 6850-6856
[Abstract]
[Full Text]
-
Hagiwara, Y., McGhee, J. R., Fujihashi, K., Kobayashi, R., Yoshino, N., Kataoka, K., Etani, Y., Kweon, M.-N., Tamura, S., Kurata, T., Takeda, Y., Kiyono, H., Fujihashi, K.
(2003). Protective Mucosal Immunity in Aging Is Associated with Functional CD4+ T Cells in Nasopharyngeal-Associated Lymphoreticular Tissue. J. Immunol.
170: 1754-1762
[Abstract]
[Full Text]
-
Boyaka, P. N., Ohmura, M., Fujihashi, K., Koga, T., Yamamoto, M., Kweon, M.-N., Takeda, Y., Jackson, R. J., Kiyono, H., Yuki, Y., McGhee, J. R.
(2003). Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit. J. Immunol.
170: 454-462
[Abstract]
[Full Text]
-
Bagley, K. C., Abdelwahab, S. F., Tuskan, R. G., Fouts, T. R., Lewis, G. K.
(2002). Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J. Leukoc. Biol.
72: 962-969
[Abstract]
[Full Text]
-
Bagley, K. C., Abdelwahab, S. F., Tuskan, R. G., Fouts, T. R., Lewis, G. K.
(2002). Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway. Infect. Immun.
70: 5533-5539
[Abstract]
[Full Text]
-
Sanchez, J., Wallerstrom, G., Fredriksson, M., Angstrom, J., Holmgren, J.
(2002). Detoxification of Cholera Toxin without Removal of Its Immunoadjuvanticity by the Addition of (STa-related) Peptides to the Catalytic Subunit. A POTENTIAL NEW STRATEGY TO GENERATE IMMUNOSTIMULANTS FOR VACCINATION. J. Biol. Chem.
277: 33369-33377
[Abstract]
[Full Text]
-
Beignon, A.-S., Briand, J.-P., Rappuoli, R., Muller, S., Partidos, C. D.
(2002). The LTR72 Mutant of Heat-Labile Enterotoxin of Escherichia coli Enhances the Ability of Peptide Antigens To Elicit CD4+ T Cells and Secrete Gamma Interferon after Coapplication onto Bare Skin. Infect. Immun.
70: 3012-3019
[Abstract]
[Full Text]
-
Millar, D. G., Hirst, T. R., Snider, D. P.
(2001). Escherichia coli Heat-Labile Enterotoxin B Subunit Is a More Potent Mucosal Adjuvant than Its Closely Related Homologue, the B Subunit of Cholera Toxin. Infect. Immun.
69: 3476-3482
[Abstract]
[Full Text]
-
Stiles, B. G., Garza, A. R., Ulrich, R. G., Boles, J. W.
(2001). Mucosal Vaccination with Recombinantly Attenuated Staphylococcal Enterotoxin B and Protection in a Murine Model. Infect. Immun.
69: 2031-2036
[Abstract]
[Full Text]
-
Richards, C. M., Aman, A. T., Hirst, T. R., Hill, T. J., Williams, N. A.
(2001). Protective Mucosal Immunity to Ocular Herpes Simplex Virus Type 1 Infection in Mice by Using Escherichia coli Heat-Labile Enterotoxin B Subunit as an Adjuvant. J. Virol.
75: 1664-1671
[Abstract]
[Full Text]
-
Belyakov, I. M., Ahlers, J. D., Clements, J. D., Strober, W., Berzofsky, J. A.
(2000). Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL. J. Immunol.
165: 6454-6462
[Abstract]
[Full Text]
-
van Ginkel, F. W., Jackson, R. J., Yuki, Y., McGhee, J. R.
(2000). Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues. J. Immunol.
165: 4778-4782
[Abstract]
[Full Text]
-
Agren, L., Sverremark, E., Ekman, L., Schon, K., Lowenadler, B., Fernandez, C., Lycke, N.
(2000). The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects. J. Immunol.
164: 6276-6286
[Abstract]
[Full Text]
-
Yamamoto, M., Rennert, P., McGhee, J. R., Kweon, M.-N., Yamamoto, S., Dohi, T., Otake, S., Bluethmann, H., Fujihashi, K., Kiyono, H.
(2000). Alternate Mucosal Immune System: Organized Peyer's Patches Are Not Required for IgA Responses in the Gastrointestinal Tract. J. Immunol.
164: 5184-5191
[Abstract]
[Full Text]
-
Weltzin, R., Guy, B., Thomas, W. D. Jr., Giannasca, P. J., Monath, T. P.
(2000). Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection. Infect. Immun.
68: 2775-2782
[Abstract]
[Full Text]
-
Simmons, C. P., Mastroeni, P., Fowler, R., Ghaem-maghami, M., Lycke, N., Pizza, M., Rappuoli, R., Dougan, G.
(1999). MHC Class I-Restricted Cytotoxic Lymphocyte Responses Induced by Enterotoxin-Based Mucosal Adjuvants. J. Immunol.
163: 6502-6510
[Abstract]
[Full Text]
-
Fujihashi, K., Dohi, T., Kweon, M.-N., Mcghee, J. R., Koga, T., Cooper, M. D., Tonegawa, S., Kiyono, H.
(1999). {gamma}{delta}T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int Immunol
11: 1907-1916
[Abstract]
[Full Text]
-
MASTROENI, P, BOWE, F, CAHILL, R, SIMMONS, C, DOUGAN, G
(1999). Vaccines against gut pathogens. Gut
45: 633-635
[Full Text]
-
Williamson, E., Westrich, G. M., Viney, J. L.
(1999). Modulating Dendritic Cells to Optimize Mucosal Immunization Protocols. J. Immunol.
163: 3668-3675
[Abstract]
[Full Text]
-
Watanabe, M., Kono, T., Matsushima-Hibiya, Y., Kanazawa, T., Nishisaka, N., Kishimoto, T., Koyama, K., Sugimura, T., Wakabayashi, K.
(1999). Molecular cloning of an apoptosis-inducing protein, pierisin, from cabbage butterfly: Possible involvement of ADP-ribosylation in its activity. Proc. Natl. Acad. Sci. USA
96: 10608-10613
[Abstract]
[Full Text]
-
Yamamoto, M., Kiyono, H., Yamamoto, S., Batanero, E., Kweon, M.-N., Otake, S., Azuma, M., Takeda, Y., McGhee, J. R.
(1999). Direct Effects on Antigen-Presenting Cells and T Lymphocytes Explain the Adjuvanticity of a Nontoxic Cholera Toxin Mutant. J. Immunol.
162: 7015-7021
[Abstract]
[Full Text]
-
Staats, H. F., Ennis, F. A. Jr.
(1999). IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens. J. Immunol.
162: 6141-6147
[Abstract]
[Full Text]
-
Kweon, M.-N., Fujihashi, K., Wakatsuki, Y., Koga, T., Yamamoto, M., McGhee, J. R., Kiyono, H.
(1999). Mucosally Induced Systemic T Cell Unresponsiveness to Ovalbumin Requires CD40 Ligand-CD40 Interactions. J. Immunol.
162: 1904-1909
[Abstract]
[Full Text]
-
Agren, L. C., Ekman, L., Lowenadler, B., Nedrud, J. G., Lycke, N. Y.
(1999). Adjuvanticity of the Cholera Toxin A1-Based Gene Fusion Protein, CTA1-DD, Is Critically Dependent on the ADP-Ribosyltransferase and Ig-Binding Activity. J. Immunol.
162: 2432-2440
[Abstract]
[Full Text]
-
Peterson, J. W., Finkelstein, R. A., Cantu, J., Gessell, D. L., Chopra, A. K.
(1999). Cholera Toxin B Subunit Activates Arachidonic Acid Metabolism. Infect. Immun.
67: 794-799
[Abstract]
[Full Text]
-
Agren, L., Norin, M., Lycke, N., Lowenadler, B.
(1999). Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DD. Protein Eng Des Sel
12: 173-178
[Abstract]
[Full Text]
-
Rani, D. B. R., Bayer, M. E., Schifferli, D. M.
(1999). Polymeric Display of Immunogenic Epitopes from Herpes Simplex Virus and Transmissible Gastroenteritis Virus Surface Proteins on an Enteroadherent Fimbria. CVI
6: 30-40
[Abstract]
[Full Text]
-
Imaoka, K., Miller, C. J., Kubota, M., McChesney, M. B., Lohman, B., Yamamoto, M., Fujihashi, K., Someya, K., Honda, M., McGhee, J. R., Kiyono, H.
(1998). Nasal Immunization of Nonhuman Primates with Simian Immunodeficiency Virus p55gag and Cholera Toxin Adjuvant Induces Th1/Th2 Help for Virus-Specific Immune Responses in Reproductive Tissues. J. Immunol.
161: 5952-5958
[Abstract]
[Full Text]
-
Yamamoto, M., Briles, D. E., Yamamoto, S., Ohmura, M., Kiyono, H., McGhee, J. R.
(1998). A Nontoxic Adjuvant for Mucosal Immunity to Pneumococcal Surface Protein A. J. Immunol.
161: 4115-4121
[Abstract]
[Full Text]
-
Matousek, M. P., Nedrud, J. G., Cieplak, W. Jr., Harding, C. V.
(1998). Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit. Infect. Immun.
66: 3480-3484
[Abstract]
[Full Text]
-
O'Neal, C. M., Clements, J. D., Estes, M. K., Conner, M. E.
(1998). Rotavirus 2/6 Viruslike Particles Administered Intranasally with Cholera Toxin, Escherichia coli Heat-Labile Toxin (LT), and LT-R192G Induce Protection from Rotavirus Challenge. J. Virol.
72: 3390-3393
[Abstract]
[Full Text]
-
Yamamoto, S., Kiyono, H., Yamamoto, M., Imaoka, K., Yamamoto, M., Fujihashi, K., Van Ginkel, F. W., Noda, M., Takeda, Y., McGhee, J. R.
(1997). A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA
94: 5267-5272
[Abstract]
[Full Text]